Cargando…

Self-Assembly of Angiotensin-Converting Enzyme Inhibitors Captopril and Lisinopril and Their Crystal Structures

[Image: see text] The peptide angiotensin-converting enzyme inhibitors captopril and lisinopril are unexpectedly shown to exhibit critical aggregation concentration (CAC) behavior through measurements of surface tension, electrical conductivity, and dye probe fluorescence. These three measurements p...

Descripción completa

Detalles Bibliográficos
Autores principales: Castelletto, Valeria, Seitsonen, Jani, Ruokolainen, Janne, Barnett, Sarah A., Sandu, Callum, Hamley, Ian W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397397/
https://www.ncbi.nlm.nih.gov/pubmed/34292730
http://dx.doi.org/10.1021/acs.langmuir.1c01340
_version_ 1783744605677682688
author Castelletto, Valeria
Seitsonen, Jani
Ruokolainen, Janne
Barnett, Sarah A.
Sandu, Callum
Hamley, Ian W.
author_facet Castelletto, Valeria
Seitsonen, Jani
Ruokolainen, Janne
Barnett, Sarah A.
Sandu, Callum
Hamley, Ian W.
author_sort Castelletto, Valeria
collection PubMed
description [Image: see text] The peptide angiotensin-converting enzyme inhibitors captopril and lisinopril are unexpectedly shown to exhibit critical aggregation concentration (CAC) behavior through measurements of surface tension, electrical conductivity, and dye probe fluorescence. These three measurements provide similar values for the CAC, and there is also evidence from circular dichroism spectroscopy for a possible conformational change in the peptides at the same concentration. Cryogenic transmission electron microscopy indicates the formation of micelle-like aggregates above the CAC, which can thus be considered a critical micelle concentration, and the formation of aggregates with a hydrodynamic radius of ∼6–7 nm is also evidenced by dynamic light scattering. We also used synchrotron radiation X-ray diffraction to determine the single-crystal structure of captopril and lisinopril. Our results improve the accuracy of previous data reported in the literature, obtained using conventional X-ray sources. We also studied the structure of aqueous solutions containing captopril or lisinopril at high concentrations. The aggregation may be driven by intermolecular interactions between the proline moiety of captopril molecules or between the phenylalanine moiety of lisinopril molecules.
format Online
Article
Text
id pubmed-8397397
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-83973972021-08-31 Self-Assembly of Angiotensin-Converting Enzyme Inhibitors Captopril and Lisinopril and Their Crystal Structures Castelletto, Valeria Seitsonen, Jani Ruokolainen, Janne Barnett, Sarah A. Sandu, Callum Hamley, Ian W. Langmuir [Image: see text] The peptide angiotensin-converting enzyme inhibitors captopril and lisinopril are unexpectedly shown to exhibit critical aggregation concentration (CAC) behavior through measurements of surface tension, electrical conductivity, and dye probe fluorescence. These three measurements provide similar values for the CAC, and there is also evidence from circular dichroism spectroscopy for a possible conformational change in the peptides at the same concentration. Cryogenic transmission electron microscopy indicates the formation of micelle-like aggregates above the CAC, which can thus be considered a critical micelle concentration, and the formation of aggregates with a hydrodynamic radius of ∼6–7 nm is also evidenced by dynamic light scattering. We also used synchrotron radiation X-ray diffraction to determine the single-crystal structure of captopril and lisinopril. Our results improve the accuracy of previous data reported in the literature, obtained using conventional X-ray sources. We also studied the structure of aqueous solutions containing captopril or lisinopril at high concentrations. The aggregation may be driven by intermolecular interactions between the proline moiety of captopril molecules or between the phenylalanine moiety of lisinopril molecules. American Chemical Society 2021-07-22 2021-08-03 /pmc/articles/PMC8397397/ /pubmed/34292730 http://dx.doi.org/10.1021/acs.langmuir.1c01340 Text en © 2021 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Castelletto, Valeria
Seitsonen, Jani
Ruokolainen, Janne
Barnett, Sarah A.
Sandu, Callum
Hamley, Ian W.
Self-Assembly of Angiotensin-Converting Enzyme Inhibitors Captopril and Lisinopril and Their Crystal Structures
title Self-Assembly of Angiotensin-Converting Enzyme Inhibitors Captopril and Lisinopril and Their Crystal Structures
title_full Self-Assembly of Angiotensin-Converting Enzyme Inhibitors Captopril and Lisinopril and Their Crystal Structures
title_fullStr Self-Assembly of Angiotensin-Converting Enzyme Inhibitors Captopril and Lisinopril and Their Crystal Structures
title_full_unstemmed Self-Assembly of Angiotensin-Converting Enzyme Inhibitors Captopril and Lisinopril and Their Crystal Structures
title_short Self-Assembly of Angiotensin-Converting Enzyme Inhibitors Captopril and Lisinopril and Their Crystal Structures
title_sort self-assembly of angiotensin-converting enzyme inhibitors captopril and lisinopril and their crystal structures
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397397/
https://www.ncbi.nlm.nih.gov/pubmed/34292730
http://dx.doi.org/10.1021/acs.langmuir.1c01340
work_keys_str_mv AT castellettovaleria selfassemblyofangiotensinconvertingenzymeinhibitorscaptoprilandlisinoprilandtheircrystalstructures
AT seitsonenjani selfassemblyofangiotensinconvertingenzymeinhibitorscaptoprilandlisinoprilandtheircrystalstructures
AT ruokolainenjanne selfassemblyofangiotensinconvertingenzymeinhibitorscaptoprilandlisinoprilandtheircrystalstructures
AT barnettsaraha selfassemblyofangiotensinconvertingenzymeinhibitorscaptoprilandlisinoprilandtheircrystalstructures
AT sanducallum selfassemblyofangiotensinconvertingenzymeinhibitorscaptoprilandlisinoprilandtheircrystalstructures
AT hamleyianw selfassemblyofangiotensinconvertingenzymeinhibitorscaptoprilandlisinoprilandtheircrystalstructures